<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35767949</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy.</ArticleTitle><Pagination><StartPage>111001</StartPage><MedlinePgn>111001</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2022.111001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(22)00790-2</ELocationID><Abstract><AbstractText>TDP-43 mediates proper Stathmin-2 (STMN2) mRNA splicing, and STMN2 protein is reduced in the spinal cord of most patients with amyotrophic lateral sclerosis (ALS). To test the hypothesis that STMN2 loss contributes to ALS pathogenesis, we generated constitutive and conditional STMN2 knockout mice. Constitutive STMN2 loss results in early-onset sensory and motor neuropathy featuring impaired motor behavior and dramatic distal neuromuscular junction (NMJ) denervation of fast-fatigable motor units, which are selectively vulnerable in ALS, without axon or motoneuron degeneration. Selective excision of STMN2 in motoneurons leads to similar NMJ pathology. STMN2 knockout heterozygous mice, which better model the partial loss of STMN2 protein found in patients with ALS, display a slowly progressive, motor-selective neuropathy with functional deficits and NMJ denervation. Thus, our findings strongly support the hypothesis that STMN2 reduction owing to TDP-43 pathology contributes to ALS pathogenesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krus</LastName><ForeName>Kelsey L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Medical Scientist Training Program, Washington University in St. Louis, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Yurie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devault</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>A Joseph</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Needleman Center for Neurometabolism and Axonal Therapeutics, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milbrandt</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110, USA; Needleman Center for Neurometabolism and Axonal Therapeutics, St. Louis, MO 63110, USA. Electronic address: jmilbrandt@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiAntonio</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Needleman Center for Neurometabolism and Axonal Therapeutics, St. Louis, MO 63110, USA. Electronic address: diantonio@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R37 NS065053</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS087632</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG013730</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 NS117784</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS119812</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050777">Stathmin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512849">Stmn2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050777" MajorTopicYN="Y">Stathmin</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CP: Neuroscience</Keyword><Keyword MajorTopicYN="N">NMNAT2</Keyword><Keyword MajorTopicYN="N">SARM1</Keyword><Keyword MajorTopicYN="N">SCG-10</Keyword><Keyword MajorTopicYN="N">axon degeneration</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuropathy</Keyword><Keyword MajorTopicYN="N">stathmin</Keyword></KeywordList><CoiStatement>Declaration of interests A.D. and J.M. are co-founders, scientific advisory board members, and shareholders of Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly. A.J.B. is a consultant to Disarm Therapeutics. The authors have no other competing conflicts or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35767949</ArticleId><ArticleId IdType="mid">NIHMS1819970</ArticleId><ArticleId IdType="pmc">PMC9327139</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2022.111001</ArticleId><ArticleId IdType="pii">S2211-1247(22)00790-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbade J, Klemetti MM, Farrell A, Ermini L, Gillmore T, Sallais J, Tagliaferro A, Post M, and Caniggia I (2020). Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis? BMJ Open Diabetes. Res Care. 8, e000923. 10.1136/bmjdrc-2019-000923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2019-000923</ArticleId><ArticleId IdType="pmc">PMC7059528</ArticleId><ArticleId IdType="pubmed">32144130</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DJ, and Axel R (1985). Molecular probes for the development and plasticity of neural crest derivatives. Cell 42, 649&#x2013;662. 10.1016/0092-8674(85)90122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(85)90122-9</ArticleId><ArticleId IdType="pubmed">3839717</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki T, Sasaki Y, and Milbrandt J (2004). Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010&#x2013;1013. 10.1126/science.1098014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1098014</ArticleId><ArticleId IdType="pubmed">15310905</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsumi T (1981). The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol. 55, 193&#x2013;198. 10.1007/bf00691318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00691318</ArticleId><ArticleId IdType="pubmed">7349578</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu H, Ding L, Pekkurnaz G, Cronin M, and Schwarz TL (2020). Kymolyzer, a semi-autonomous kymography tool to analyze intracellular motility. Curr. Protoc. Cell Biol 87, e107. 10.1002/cpcb.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpcb.107</ArticleId><ArticleId IdType="pmc">PMC8989283</ArticleId><ArticleId IdType="pubmed">32530579</ArticleId></ArticleIdList></Reference><Reference><Citation>Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Mich&#xe1;n S, Baloh RH, Golden JP, Schmidt RE, et al. (2011). Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par3/atypical protein kinase C (aPKC) signaling. Proc. Natl. Acad. Sci. U S A 108, E952&#x2013;E961. 10.1073/pnas.1104969108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1104969108</ArticleId><ArticleId IdType="pmc">PMC3203793</ArticleId><ArticleId IdType="pubmed">21949390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom AJ, Mao X, Strickland A, Sasaki Y, Milbrandt J, and DiAntonio A (2022). Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients. Mol. Neurodegener. 17, 1. 10.1186/s13024-021-00511-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00511-x</ArticleId><ArticleId IdType="pmc">PMC8739729</ArticleId><ArticleId IdType="pubmed">34991663</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, et al. (2022). TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131&#x2013;137. 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, and Ironton R (1978). Sprouting and regression of neuromuscular synapses in partially denervated mammalian muscles. J. Physiol. 278, 325&#x2013;348. 10.1113/jphysiol.1978.sp012307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1978.sp012307</ArticleId><ArticleId IdType="pmc">PMC1282352</ArticleId><ArticleId IdType="pubmed">671308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, et al. (2007). TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171, 227&#x2013;240. 10.2353/ajpath.2007.070182.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.070182</ArticleId><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Montiel MJ, Chaineau M, and Durcan TM (2020). The neglected genes of ALS: cytoskeletal dynamics impact synaptic degeneration in ALS. Front. Cell. Neurosci. 14, 594975. 10.3389/fncel.2020.594975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.594975</ArticleId><ArticleId IdType="pmc">PMC7691654</ArticleId><ArticleId IdType="pubmed">33281562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL (1994). Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55&#x2013;63. 10.1016/0165-0270(94)90144-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0270(94)90144-9</ArticleId><ArticleId IdType="pubmed">7990513</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Collingwood TN, Frodin M, and Davis GD (2011). High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat. Methods 8, 753&#x2013;755. 10.1038/nmeth.1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1653</ArticleId><ArticleId IdType="pmc">PMC3617923</ArticleId><ArticleId IdType="pubmed">21765410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertkova AO, Mastop M, Postma M, van Bommel N, van der Niet S, Batenburg KL, Joosen L, Gadella TWJ, Okada Y, and Goedhart J (2017). Robust and bright genetically encoded fluorescent markers for highlighting structures and compartments in mammalian cells. Preprint at bioRxiv. 10.1101/160374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/160374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, and Offen D (2011). The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 43, 470&#x2013;477. 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengler R, Konstanzer A, K&#xfc;ther G, Hesse S, Wolf W, and Strupplerdr A (1990). Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve 13, 545&#x2013;550. 10.1002/mus.880130612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880130612</ArticleId><ArticleId IdType="pubmed">2366827</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Paolo G, Lutjens R, Osen-Sand A, Sobel A, Catsicas S, and Grenningloh G (1997). Differential distribution of stathmin and SCG10 in developing neurons in culture. J. Neurosci. Res. 50, 1000&#x2013;1009. 10.1002/(sici)1097-4547(19971215)50:6&amp;lt;1000::aid-jnr10&amp;gt;3.0.co;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4547(19971215)50:6&amp;lt;1000::aid-jnr10&amp;gt;3.0.co;2-8</ArticleId><ArticleId IdType="pubmed">9452014</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon WJ (1980). Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20, 441&#x2013;462. 10.1146/annurev.pa.20.040180.002301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pa.20.040180.002301</ArticleId><ArticleId IdType="pubmed">7387124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebenezer GJ, McArthur JC, Thomas D, Murinson B, Hauer P, Polydefkis M, and Griffin JW (2007). Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain 130, 2703&#x2013;2714. 10.1093/brain/awm199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm199</ArticleId><ArticleId IdType="pubmed">17898011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein SY, Yagudayeva I, and Shneider NA (2019). Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 26, 364&#x2013;373.e4. 10.1016/j.celrep.2018.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.045</ArticleId><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Essuman K, Summers DW, Sasaki Y, Mao X, DiAntonio A, and Milbrandt J (2017). The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration. Neuron 93, 1334&#x2013;1343.e5. 10.1016/j.neuron.2017.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.022</ArticleId><ArticleId IdType="pmc">PMC6284238</ArticleId><ArticleId IdType="pubmed">28334607</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, and DiAntonio A (2020). The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease. Curr. Opin. Neurobiol. 63, 59&#x2013;66. 10.1016/j.conb.2020.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2020.02.012</ArticleId><ArticleId IdType="pmc">PMC7483800</ArticleId><ArticleId IdType="pubmed">32311648</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, Gu W, Nanson JD, Shi Y, Sasaki Y, Cunnea K, Malde AK, Jia X, Luo Z, Saikot FK, et al. (2021). SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration. Neuron 109, 1118&#x2013;1136.e11. 10.1016/j.neuron.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC8174188</ArticleId><ArticleId IdType="pubmed">33657413</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD, et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232&#x2013;240. 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, and Caroni P (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534&#x2013;2542. 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Doan RA, Cheng GC, Cetinkaya-Fisgin A, Huang SX, H&#xf6;ke A, Milbrandt J, and DiAntonio A (2019). Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight 4, e129920. 10.1172/jci.insight.129920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.129920</ArticleId><ArticleId IdType="pmc">PMC6777905</ArticleId><ArticleId IdType="pubmed">31484833</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Doan RA, Strickland A, Huang X, Milbrandt J, and DiAntonio A (2016). Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain 139, 3092&#x2013;3108. 10.1093/brain/aww251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww251</ArticleId><ArticleId IdType="pmc">PMC5840884</ArticleId><ArticleId IdType="pubmed">27797810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdts J, Summers DW, Sasaki Y, DiAntonio A, and Milbrandt J (2013). Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J. Neurosci. 33, 13569&#x2013;13580. 10.1523/JNEUROSCI.1197-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1197-13.2013</ArticleId><ArticleId IdType="pmc">PMC3742939</ArticleId><ArticleId IdType="pubmed">23946415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, van Eijk KR, Goutman SA, Harms MB, Houlden H, et al. (2021). Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife 10, e70905. 10.7554/eLife.70905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70905</ArticleId><ArticleId IdType="pmc">PMC8735862</ArticleId><ArticleId IdType="pubmed">34796871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Orsomando G, Nascimento-Ferreira I, and Coleman MP (2015). Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Rep. 10, 1974&#x2013;1981. 10.1016/j.celrep.2015.02.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.02.060</ArticleId><ArticleId IdType="pmc">PMC4386025</ArticleId><ArticleId IdType="pubmed">25818290</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf ER, Heerssen HM, Wright CM, Davis GW, and DiAntonio A (2011). Stathmin is required for stability of the Drosophila neuromuscular junction. J. Neurosci. 31, 15026&#x2013;15034. 10.1523/JNEUROSCI.2024-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2024-11.2011</ArticleId><ArticleId IdType="pmc">PMC3207242</ArticleId><ArticleId IdType="pubmed">22016536</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra San Juan I, Nash LA, Smith KS, Leyton-Jaimes MF, Qian M, Klim JR, Limone F, Dorr AB, Couto A, Pintacuda G, et al. (2022). Loss of mouse Stmn2 function causes motor neuropathy. Neuron 110, 1671&#x2013;1688.e6. 10.1016/j.neuron.2022.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.02.011</ArticleId><ArticleId IdType="pmc">PMC9119928</ArticleId><ArticleId IdType="pubmed">35294901</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobs MA, Dimitracopoulos A, and Franze K (2019). KymoButler, a deep learning software for automated kymograph analysis. Elife 8, e42288. 10.7554/eLife.42288.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.42288</ArticleId><ArticleId IdType="pmc">PMC6692109</ArticleId><ArticleId IdType="pubmed">31405451</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, et al. (2022). A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Ann. Clin. Transl. Neurol. 9, 50&#x2013;66. 10.1002/acn3.51491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51491</ArticleId><ArticleId IdType="pmc">PMC8791798</ArticleId><ArticleId IdType="pubmed">35014217</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Pintacuda G, Nash LA, Guerra San Juan I, and Eggan K (2021). Connecting TDP-43 pathology with neuropathy. Trends Neurosci. 44, 424&#x2013;440. 10.1016/j.tins.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.02.008</ArticleId><ArticleId IdType="pubmed">33832769</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, Burberry A, Steinbaugh MJ, Gamage KK, Kirchner R, et al. (2019). ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167&#x2013;179. 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, and Shneider NA (2022). Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat. Med. 28, 104&#x2013;116. 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pichon CE, Meilandt WJ, Dominguez S, Solanoy H, Lin H, Ngu H, Gogineni A, Sengupta Ghosh A, Jiang Z, Lee SH, Maloney J, et al. (2017). Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci. Transl. Med. 9, eaag0394. 10.1126/scitranslmed.aag0394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag0394</ArticleId><ArticleId IdType="pubmed">28814543</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedtke W, Leman EE, Fyffe RE, Raine CS, and Schubart UK (2002). Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am. J. Pathol. 160, 469&#x2013;480. 10.1016/S0002-9440(10)64866-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64866-3</ArticleId><ArticleId IdType="pmc">PMC1850667</ArticleId><ArticleId IdType="pubmed">11839567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, and Wong PC (2015). TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650&#x2013;655. 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, and Cleveland DW (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438. 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, Briner A, Rodriguez CM, Guo C, Akiyama T, et al. (2022). TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603, 124&#x2013;130. 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. (2019). Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337. 10.1038/s41586-019-1195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW, et al. (2019). Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180&#x2013;190. 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Meneses A, Koga S, O&#x2019;Leary J, Dickson DW, Bu G, and Zhao N (2021). TDP-43 pathology in alzheimer&#x2019;s disease. Mol. Neurodegener. 16, 84. 10.1186/s13024-021-00503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00503-x</ArticleId><ArticleId IdType="pmc">PMC8691026</ArticleId><ArticleId IdType="pubmed">34930382</ArticleId></ArticleIdList></Reference><Reference><Citation>Morii H, Shiraishi-Yamaguchi Y, and Mori N (2006). SCG10, a microtubule destabilizing factor, stimulates the neurite outgrowth by modulating microtubule dynamics in rat hippocampal primary cultured neurons. J. Neurobiol. 66, 1101&#x2013;1114. 10.1002/neu.20295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.20295</ArticleId><ArticleId IdType="pubmed">16838365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, and Schneider JA (2018). TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 6, 33. 10.1186/s40478-018-0531-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0531-3</ArticleId><ArticleId IdType="pmc">PMC5928580</ArticleId><ArticleId IdType="pubmed">29716643</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, et al. (2012). dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337, 481&#x2013;484. 10.1126/science.1223899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1223899</ArticleId><ArticleId IdType="pmc">PMC5225956</ArticleId><ArticleId IdType="pubmed">22678360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozon S, Byk T, and Sobel A (1998). SCLIP: a novel SCG10-like protein of the stathmin family expressed in the nervous system. J. Neurochem. 70, 2386&#x2013;2396. 10.1046/j.1471-4159.1998.70062386.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.70062386.x</ArticleId><ArticleId IdType="pubmed">9603203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozon S, Maucuer A, and Sobel A (1997). The stathmin family &#x2013; molecular and biological characterization of novel mammalian proteins expressed in the nervous system. Eur. J. Biochem. 248, 794&#x2013;806. 10.1111/j.1432-1033.1997.t01-2-00794.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1997.t01-2-00794.x</ArticleId><ArticleId IdType="pubmed">9342231</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, and Patel BK (2019). Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12, 25. 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Humphrey J, Pickles S, Brown AL, Hill SE, Kachergus JM, Shi J, Heckman MG, Spiegel MR, Cook C, et al. (2020). Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130, 6080&#x2013;6092. 10.1172/jci139741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci139741</ArticleId><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Paz-Fajardo L, and L&#xf3;pez de Muna&#xed;n A (2021). Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis. Br. J. Pharmacol. 178, 1257&#x2013;1268. 10.1111/bph.15202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15202</ArticleId><ArticleId IdType="pubmed">32673410</ArticleId></ArticleIdList></Reference><Reference><Citation>Riederer BM, Pellier V, Antonsson B, Di Paolo G, Stimpson SA, L&#xfc;tjens R, L&#xfc;tjens R, Catsicas S, and Grenningloh G (1997). Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10. Proc. Natl. Acad. Sci. U S A 94, 741&#x2013;745. 10.1073/pnas.94.2.741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.2.741</ArticleId><ArticleId IdType="pmc">PMC19584</ArticleId><ArticleId IdType="pubmed">9012855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjana NE, Shalem O, and Zhang F (2014). Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783&#x2013;784. 10.1038/nmeth.3047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3047</ArticleId><ArticleId IdType="pmc">PMC4486245</ArticleId><ArticleId IdType="pubmed">25075903</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Engber TM, Hughes RO, Figley MD, Wu T, Bosanac T, Devraj R, Milbrandt J, Krauss R, and DiAntonio A (2020). cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Exp. Neurol. 329, 113252. 10.1016/j.expneurol.2020.113252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113252</ArticleId><ArticleId IdType="pmc">PMC7302925</ArticleId><ArticleId IdType="pubmed">32087251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Hackett AR, Kim S, Strickland A, and Milbrandt J (2018). Dysregulation of NAD+ metabolism induces a Schwann cell dedifferentiation program. J. Neurosci. 38, 6546&#x2013;6562. 10.1523/JNEUROSCI.3304-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3304-17.2018</ArticleId><ArticleId IdType="pmc">PMC6052240</ArticleId><ArticleId IdType="pubmed">29921717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Nakagawa T, Mao X, DiAntonio A, and Milbrandt J (2016). NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion. Elife 5, e19749. 10.7554/eLife.19749.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19749</ArticleId><ArticleId IdType="pmc">PMC5063586</ArticleId><ArticleId IdType="pubmed">27735788</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, and Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671&#x2013;675. 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentmanat MF, White JM, Kouranova E, and Cui X (2022). Highly reliable creation of floxed alleles by electroporating single-cell embryos. BMC Biol. 20, 31. 10.1186/s12915-021-01223-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-021-01223-w</ArticleId><ArticleId IdType="pmc">PMC8815186</ArticleId><ArticleId IdType="pubmed">35115009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Lyashchenko AK, Lu L, Nasrabady SE, Elmaleh M, Mendelsohn M, Nemes A, Tapia JC, Mentis GZ, and Shneider NA (2016). ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 7, 10465. 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JE, Geisler S, and DiAntonio A (2014). Dynamic regulation of SCG10 in regenerating axons after injury. Exp. Neurol. 252, 1&#x2013;11. 10.1016/j.expneurol.2013.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.11.007</ArticleId><ArticleId IdType="pmc">PMC3947015</ArticleId><ArticleId IdType="pubmed">24246279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JE, Miller BR, Babetto E, Cho Y, Sasaki Y, Qayum S, Russler EV, Cavalli V, Milbrandt J, and DiAntonio A (2012). SCG10 is a JNK target in the axonal degeneration pathway. Proc. Natl. Acad. Sci. U S A 109, E3696&#x2013;E3705. 10.1073/pnas.1216204109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1216204109</ArticleId><ArticleId IdType="pmc">PMC3535671</ArticleId><ArticleId IdType="pubmed">23188802</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Cheung CJ, Restrepo CR, Kwong LK, Stieber AM, Trojanowski JQ, and Lee VMY (2016). Selective motor neuron resistance and recovery in a new inducible mouse model of TDP-43 proteinopathy. J. Neurosci. 36, 7707&#x2013;7717. 10.1523/JNEUROSCI.1457-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1457-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705561</ArticleId><ArticleId IdType="pubmed">27445147</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers DW, Frey E, Walker LJ, Milbrandt J, and DiAntonio A (2020). DLK activation synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-dependent axon degeneration. Mol. Neurobiol. 57, 1146&#x2013;1158. 10.1007/s12035-019-01796-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01796-2</ArticleId><ArticleId IdType="pmc">PMC7035184</ArticleId><ArticleId IdType="pubmed">31696428</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers DW, Milbrandt J, and DiAntonio A (2018). Palmitoylation enables MAPK-dependent proteostasis of axon survival factors. Proc. Natl. Acad. Sci. U S A 115, E8746&#x2013;E8754. 10.1073/pnas.1806933115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806933115</ArticleId><ArticleId IdType="pmc">PMC6140512</ArticleId><ArticleId IdType="pubmed">30150401</ArticleId></ArticleIdList></Reference><Reference><Citation>Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, and Diamond MS (2009). The immune adaptor molecule SARM modulates tumor necrosis factor Alpha production and microglia activation in the brainstem and restricts west nile virus pathogenesis. J. Virol. 83, 9329&#x2013;9338. 10.1128/jvi.00836-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00836-09</ArticleId><ArticleId IdType="pmc">PMC2738257</ArticleId><ArticleId IdType="pubmed">19587044</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F, Anderton RS, Mastaglia FL, Flynn LL, Winter SJ, James I, Bedlack R, Hodgetts S, Fletcher S, Wilton SD, Laing NG, MacShane M, Needham M, Saunders A, Mackay-Sim A, Melamed Z, Ravits J, Cleveland DW, and Akkari PA (2021). Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Front. Aging Neurosci. 13, 658226. 10.3389/fnagi.2021.658226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.658226</ArticleId><ArticleId IdType="pmc">PMC8033025</ArticleId><ArticleId IdType="pubmed">33841129</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, et al. (2009). Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 41, 1083&#x2013;7. 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, and van den Berg LH (2017). Amyotrophic lateral sclerosis. Lancet 390, 2084&#x2013;2098. 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LJ, Summers DW, Sasaki Y, Brace EJ, Milbrandt J, and DiAntonio A (2017). MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. Elife 6, e22540. 10.7554/eLife.22540.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.22540</ArticleId><ArticleId IdType="pmc">PMC5241118</ArticleId><ArticleId IdType="pubmed">28095293</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Y, Wang M, Song WM, Shen Q, McKenzie A, Choi I, Zhou X, Pan PY, Yue Z, and Zhang B (2019). The landscape of multiscale transcriptomic networks and key regulators in Parkinson&#x2019;s disease. Nat. Commun. 10, 5234. 10.1038/s41467-019-13144-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13144-y</ArticleId><ArticleId IdType="pmc">PMC6868244</ArticleId><ArticleId IdType="pubmed">31748532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA, and Schneider JA (2013). TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 70, 1418. 10.1001/jamaneurol.2013.3961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3961</ArticleId><ArticleId IdType="pmc">PMC3830649</ArticleId><ArticleId IdType="pubmed">24080705</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>